This AIM white paper synthesizes information gathered from immunization program leaders to highlight the four key elements of a successful flu vaccination campaign and outline associated strategies.
Explore AIM's hub of resources for communications and education around the flu vaccine. Materials developed by AIM and our partners are included in this collection.
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.
